Institutional investors purchased a net $959.5 thousand shares of TRNX during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 74.08% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 1.3 Thousand shares of Tornier NV